|
|
Become a Patron!
Jimi's Daily Health Articles
- Thread starter Jimi
- Start date
| ||
| ||
| ||
|
.
- 10 Best Healing Essential Oils - From eucalyptus for respiratory health to frankincense for inflammation, these are some of our favorite "must-have" essential oils. Learn how to use them effectively for specific health concerns.
- DIY Calendula Oil - Learn how to infuse dried calendula into a nourishing oil that calms irritation, supports wound healing, and can be used in salves, creams, and gentle baby-care recipes.
- Healing Power of Positive Thinking- Positive thinking isn't just "woowoo" and does more than you think. Reduce stress, improve immune function, and aid in recovery from chronic illnesses.
- Homemade Veggie Omelet with Herbs & Oils - A protein-rich omelet packed with greens, fresh herbs, and optional culinary essential oils like basil or dill. Includes dairy-free swaps and six creative flavor variations.
|
|
|
|
|
|
|
|
|
|
An Herbicide that Works Like Chemotherapy
Monsanto seized the opportunity presented by the rise of Roundup-resistant “superweeds” to develop additional genetically engineered traits so crops like corn could soak up a wide range of herbicides, including 2,4-D, dicamba, glufosinate, and others such as imazamox, isoxaflutole, mesotrione, oxynil, sulfonylurea, and HPPD-inhibiting herbicides.Farmers continue to struggle with herbicide-resistant weeds. So, Bayer, which bought Monsanto and retired its infamous name in 2018, is getting ready to roll out icafolin-methyl, its first new herbicide in over 30 years, one that the company says has “exceptional safety.” And, yes, they’re genetically engineering crops to tolerate it.
There’s no reason to believe Bayer that icafolin-methyl is safe, but as Claire Robinson of GMWatch conceded, “there’s little to no information available on its possible toxicity to humans or the environment.”
Icafolin-methyl’s mode of action could help us predict how it might impact human health, but what exactly that is is unclear. Robinson found an article published by Bayer scientists that “makes the remarkable admission that even they don’t understand how the herbicide works to kill plants.” They say it’s “probably by binding to ß-tubulins.”
Pharmaceuticals that target ß-tubulins are used in chemotherapy to treat cancer, a disease linked to glyphosate exposure. Will Bayer be poisoning eaters with one herbicide and “treat” them with another? Tubulin binders come with severe side effects, including toxicity to the brain and blood.
Bayer says icafolin-methyl kills weeds but is harmless to people. They told that lie about glyphosate. They expect us to believe them now?
TAKE ACTION: Tell Your State Legislators To Block Bayer’s New Icafolin-Methyl Herbicide and Genetically Engineered Crops!
ENVIRONMENT & CLIMATE
We Discovered Microbes in Bark ‘Eat’ Climate Gases. This Will Change the Way We Think About Trees
by Luke Jeffrey (Postdoctoral Research Fellow, Southern Cross University), Chris Greenig (Professor, Microbiology, Monash University), Damien Maher (Professor in Earth Sciences, Southern Cross University), Pok Man Leung (Research Fellow in Microbiology, Monash University), The Conversation:“We all know trees are climate heroes. They pull carbon dioxide out of the air, release the oxygen we breathe, and help combat climate change. Now, for the first time, our research has uncovered the hidden world of the tiny organisms living in the bark of trees. We discovered they are quietly helping to purify the air we breathe and remove greenhouse gases.
These microbes ‘eat’, or use, gases like methane and carbon monoxide for energy and survival. Most significantly, they also remove hydrogen, which has a role in super-charging climate change.
What we discovered has changed how we think about trees. Bark was long assumed to be largely biologically inert in relation to climate. But our findings show it hosts active microbial communities that influence key atmospheric gases. This means trees affect the climate in more ways than we previously realized.”
Within every tree species examined, in every forest type and at every stem height, bark microbes consistently removed hydrogen from the air
HEALTH
‘There’s a Dark Side to Floristry’: Are Pesticides Making Workers Seriously Ill – Or Worse?
Louise Donovan writes for The Guardian:“On a cold morning in December 2024, florist Madeline King was on a buying trip to her local wholesaler when a wave of dizziness nearly knocked her over. As rows of roses seemed to rush past her, she tried to focus. She quickly picked the blooms she needed and left. I’m not doing this any more, she thought.
That month, after eight years, she closed her Minneapolis-based florist. She had started the business aged 22, transforming it from a one-woman show operating out of her dad’s warehouse into a 10-person team, creating extravagant floral displays for weddings and building a loyal social media following.
The dizziness she experienced that day wasn’t new. By that point, King, 30, had spent years battling fatigue, headaches, and nausea. Her brain was foggy. She’d walk into rooms and forget why she was there. Now, she believes her symptoms were a result of pesticide exposure.
‘It was definitely earth-shattering,’ she says over Zoom. ‘To find out that I feel this bad because of my job … is horrible and stressful. And also, why is no one talking about this?’”
Read how, unlike food, there is no upper limit on pesticide residue levels in flowers in the EU, UK, or U.S.
BAN TOXIC PFAS
Forever Chemicals May Increase Liver Disease Risk in Adolescents by as Much as 3-Fold
Press Release, Keck School of Medicine of USC:“‘These findings suggest that PFAS exposures, genetics and lifestyle factors work together to influence who has greater risk of developing MASLD as a function of your life stage,’ said Max Aung, PhD, MPH, assistant professor of population and public health sciences at the Keck School of Medicine. ‘Understanding gene and environment interactions can help advance precision environmental health for MASLD.’
Li noted that this study is the first to examine PFAS and MASLD in children using gold-standard diagnostic criteria, and the first to explore how genetic and lifestyle factors may interact with PFAS exposure. MASLD also became more common as adolescents grew older, adding to evidence that puberty and early adulthood may increase susceptibility to environmental exposures.
The study builds on recent USC research showing that, for adolescents undergoing bariatric surgery to manage obesity, a PFAS known as PFHpA is linked to more severe liver disease, including inflammation and scarring of connective tissue called fibrosis.
Taken together, the two studies show that PFAS exposures not only disrupt liver biology but also translate into real liver disease risk in youth.”
Adolescence seems to be a critical window of susceptibility, suggesting PFAS exposure may matter most when the liver is still developing
TAKE ACTION: Tell Your State Legislators to Ban PFAS Pesticides!
NEW STUDY
Exercise May Be Just As Effective at Relieving Depression As Medication and Therapy
Erica Sweeney, Everyday Health:“Movement is medicine: It can strengthen your bones and muscles, help your heart, and boost your brain power.
Now, a new study provides more evidence that exercise can also reduce symptoms of depression, perhaps as much as talk therapy or antidepressants.
‘Exercise provides an option for people experiencing depressive symptoms, along with pharmacological and psychological treatments, which should be offered to people to allow them to choose the best option in consultation with their health professional,’ says the study’s lead author, Andrew Clegg, PhD, a professor of health services research at the University of Lancashire in England.
The review found that light and moderate-intensity exercise may be more beneficial than vigorous exercise, Clegg says. It also found that, unlike antidepressants, exercise for depression rarely led to unpleasant side effects.”
Research has suggested that walking, jogging, yoga, and strength training are more effective than other exercises at reducing depression symptoms
What the...
Monsanto seized the opportunity presented by the rise of Roundup-resistant “superweeds” to develop additional genetically engineered traits so crops like corn could soak up a wide range of herbicides, including 2,4-D, dicamba, glufosinate, and others such as imazamox, isoxaflutole, mesotrione, oxynil, sulfonylurea, and HPPD-inhibiting herbicides.
Farmers continue to struggle with herbicide-resistant weeds. So, Bayer, which bought Monsanto and retired its infamous name in 2018, is getting ready to roll out icafolin-methyl, its first new herbicide in over 30 years, one that the company says has “exceptional safety.” And, yes, they’re genetically engineering crops to tolerate it.
There’s no reason to believe Bayer that icafolin-methyl is safe, but as Claire Robinson of GMWatch conceded, “there’s little to no information available on its possible toxicity to humans or the environment.”
Icafolin-methyl’s mode of action could help us predict how it might impact human health, but what exactly that is is unclear. Robinson found an article published by Bayer scientists that “makes the remarkable admission that even they don’t understand how the herbicide works to kill plants.” They say it’s “probably by binding to ß-tubulins.”
Pharmaceuticals that target ß-tubulins are used in chemotherapy to treat cancer, a disease linked to glyphosate exposure. Will Bayer be poisoning eaters with one herbicide and “treat” them with another? Tubulin binders come with severe side effects, including toxicity to the brain and blood.
Bayer says icafolin-methyl kills weeds but is harmless to people. They told that lie about glyphosate. They expect us to believe them now?
TAKE ACTION: Tell Your State Legislators To Block Bayer’s New Icafolin-Methyl Herbicide and Genetically Engineered Crops!
BAYER’S NEW PLAN
An Herbicide that Works Like Chemotherapy
Monsanto seized the opportunity presented by the rise of Roundup-resistant “superweeds” to develop additional genetically engineered traits so crops like corn could soak up a wide range of herbicides, including 2,4-D, dicamba, glufosinate, and others such as imazamox, isoxaflutole, mesotrione, oxynil, sulfonylurea, and HPPD-inhibiting herbicides.
Farmers continue to struggle with herbicide-resistant weeds. So, Bayer, which bought Monsanto and retired its infamous name in 2018, is getting ready to roll out icafolin-methyl, its first new herbicide in over 30 years, one that the company says has “exceptional safety.” And, yes, they’re genetically engineering crops to tolerate it.
There’s no reason to believe Bayer that icafolin-methyl is safe, but as Claire Robinson of GMWatch conceded, “there’s little to no information available on its possible toxicity to humans or the environment.”
Icafolin-methyl’s mode of action could help us predict how it might impact human health, but what exactly that is is unclear. Robinson found an article published by Bayer scientists that “makes the remarkable admission that even they don’t understand how the herbicide works to kill plants.” They say it’s “probably by binding to ß-tubulins.”
Pharmaceuticals that target ß-tubulins are used in chemotherapy to treat cancer, a disease linked to glyphosate exposure. Will Bayer be poisoning eaters with one herbicide and “treat” them with another? Tubulin binders come with severe side effects, including toxicity to the brain and blood.
Bayer says icafolin-methyl kills weeds but is harmless to people. They told that lie about glyphosate. They expect us to believe them now?
TAKE ACTION: Tell Your State Legislators To Block Bayer’s New Icafolin-Methyl Herbicide and Genetically Engineered Crops!
Signed
EXPOSED: Undisclosed DNA Found in mRNA COVID Vaccines Using Tests Regulators Never RequiredBombshell study exposes DNA contamination in COVID-19 shots, demands immediate market withdrawal
EXPOSED: Undisclosed DNA Found in mRNA COVID Vaccines Using Tests Regulators Never RequiredBombshell study exposes DNA contamination in COVID-19 shots, demands immediate market withdrawal
lionessofjudah.substack.com
|
AFib Treatment Reduces Dementia Risk
Dr. Chauncey Crandall, M.D., writes:
A procedure to restore normal heart rhythm is more effective than medication for reducing dementia risk in people with the heart rhythm disorder atrial fibrillation (AFib).
Previous studies have shown that AFib is associated with increased risk of dementia. A new study assessed whether catheter ablation and medication for AFib reduced that risk.
Special: The Shocking Truth About Magnesium
In catheter ablation, doctors insert a tube through a blood vessel to the heart to pinpoint the source of the arrhythmia, and then use radiofrequency energy to inactivate or isolate the affected area. Researchers analyzed data on patients in South Korea who were diagnosed with AFib between 2005 and 2015, including more than 9,100 who had catheter ablation and nearly 18,000 who were treated with medication. During a 12-year follow-up, catheter ablation reduced the incidence of dementia by 27% compared to medication.
When researchers focused on specific types of dementia, they found that ablation was associated with a 23% lower incidence of Alzheimer’s disease compared to medication and a 50% decrease in vascular dementia.
After patients who suffered a stroke during follow-up were removed from the analysis, ablation was still significantly associated with a reduced risk of overall dementia and vascular dementia, but a statistically insignificant reduced risk of Alzheimer’s.
Dr. Chauncey Crandall, M.D., writes:
A procedure to restore normal heart rhythm is more effective than medication for reducing dementia risk in people with the heart rhythm disorder atrial fibrillation (AFib).
Previous studies have shown that AFib is associated with increased risk of dementia. A new study assessed whether catheter ablation and medication for AFib reduced that risk.
Special: The Shocking Truth About Magnesium
In catheter ablation, doctors insert a tube through a blood vessel to the heart to pinpoint the source of the arrhythmia, and then use radiofrequency energy to inactivate or isolate the affected area. Researchers analyzed data on patients in South Korea who were diagnosed with AFib between 2005 and 2015, including more than 9,100 who had catheter ablation and nearly 18,000 who were treated with medication. During a 12-year follow-up, catheter ablation reduced the incidence of dementia by 27% compared to medication.
When researchers focused on specific types of dementia, they found that ablation was associated with a 23% lower incidence of Alzheimer’s disease compared to medication and a 50% decrease in vascular dementia.
After patients who suffered a stroke during follow-up were removed from the analysis, ablation was still significantly associated with a reduced risk of overall dementia and vascular dementia, but a statistically insignificant reduced risk of Alzheimer’s.